TheEdgeResearch
Home / Stocks / APYI

Aspyra Inc. (APYI)

OTC Healthcare Medical - Healthcare Information Services
$0.00 ▲ +0.00%
Market Cap
$34
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Beta
0.19
52-Wk Range
0.0002-0.0002
CEO
Gary W. Bennett
Country
US
Currency
USD

Aspyra Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Jacksonville, FL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $34. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -60.9%. Its beta of 0.19 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
-1.39
Gross margin
45.9%
Operating margin
55.2%
Net margin
-60.9%
Return on equity
Debt / equity
0.53
Current ratio
0.32
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
69
IPO date
1983-09-22
Headquarters
Jacksonville, FL, US
About Aspyra Inc.

Aspyra Inc. specializes in healthcare solutions, delivering essential products and services to both the laboratory and medical imaging industries. The company provides meticulously crafted workflow systems, which encompass software, connectivity tools, physical hardware, and expert support services. These solutions are adopted by a diverse range of healthcare organizations, such as specialized and reference laboratories, medical clinics, hospitals, diagnostic imaging centers, and orthopedic practices. Established in 1978, the enterprise initially operated as Creative Computer Applications Inc., officially adopting the Aspyra Inc. name in November 2005. Its corporate headquarters are located in Jacksonville, Florida.

Comparable companies

Aspyra Inc. is most often compared with the following Healthcare names:

ACUSAOBICDXIISHILGBIMYMXNRTSFSDNISECI
More research on APYI
APYI technical analysis APYI TheEdge Score Compare against peers
Open full interactive analysis & DCF →